+0.9%
TEL vs GSK
+21.8%
-20.9%
-21.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.6% | 0.0% | +3.6% | +3.6% |
| 7D | +1.6% | -3.5% | +5.1% | +2.3% |
| 30D | -0.7% | -3.4% | +2.8% | 0.0% |
| 3M | +2.4% | -8.1% | +10.6% | +4.2% |
| 6M | +4.1% | -11.1% | +15.3% | +6.6% |
| YTD | -5.8% | +0.7% | -6.6% | -5.7% |
| 1Y | +0.9% | +20.1% | -19.3% | -2.3% |
| All | +0.9% | +21.8% | -20.9% | -2.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling